The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer.
Common cancer drug manufacturer warned by the FDA over data in India
Wracked with quality question marks that have caused major shortages of common cancer drugs, India-based generic drug manufacturer Intas Pharmaceuticals has been handed a warning